Topiramate and Valproate Compared in Treatment of Juvenile Myoclonic Epilepsy

J Gordon Millichap

doi:10.15844/pedneurbriefs-21-8-6

Topiramate and Valproate Compared in Treatment of Juvenile Myoclonic Epilepsy

Pediatric Neurology Briefs

Volume 21 (2007): Issue 8

By: J Gordon Millichap

Open Access

|Aug 2007

Abstract

A pilot, randomized, controlled trial comparing topiramate (n=19) and valproate (n=9) in adolescents/adults with juvenile myoclonic epilepsy (JME) was conducted in the Childrens Hospitals of Denver, CO, and Cincinnati, OH.

References

Levisohn PM Holland KD Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison Epilepsy Behav 2007 Jun 10 4 547 52 10.1016/j.yebeh.2007.03.003 17482520
Open DOI Search in Google Scholar Back to article
Wheless JW Clarke DF Carpenter D Treatment of pediatric epilepsy: expert opinion, 2005 J Child Neurol 2005 Dec 20 Suppl 1 S42 43 16615562
Search in Google Scholar Back to article
Eriksson K Viinikainen K Mönkkönen A Aikiä M Nieminen P Heinonen S Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development Epilepsy Res 2005 Jul 65 3 189 200 10.1016/j.eplepsyres.2005.06.001 16029946
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-21-8-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 61 - 61

Published on: Aug 1, 2007

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Juvenile Myoclonic Epilepsy,

Systemic Toxicity,

Valproate

© 2007 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 21 (2007): Issue 8